Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2016 Sep 15;11(9):e0163386. doi: 10.1371/journal.pone.0163386

Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

Cohen A T, Hamilton M, Bird A, Mitchell S A, Li X, Horblyuk R, Batson S
PMCID: PMC5025275  PMID: 27631606

The fifth authors name is spelled incorrectly. The correct name is Xiaoyan Li. The correct citation is: Cohen AT, Hamilton M, Bird A, Mitchell SA, Li X, Horblyuk R, et al. (2016) Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE 11(8): e0160064. doi:10.1371/journal.pone.0160064

Reference

  • 1.Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, et al. (2016) Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE 11(8): e0160064 doi: 10.1371/journal.pone.0160064 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES